V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009750 | 270005761 | null | 90 | Curative (C) | 2017-04-08 | 2017-04-10 | GDCVP | N | N | 270020552 | CVP R |
| 270009751 | 270005761 | 1.79 | 79 | Palliative (P) | 2015-08-17 | 2015-08-19 | COPP + Dacarbazine | N | N | 270020552 | CVP R |
| 270009752 | 270018892 | 1.81 | 78.4 | Curative (C) | 2018-01-16 | 2018-01-23 | DHAP | 02 | Y | 270020574 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270009753 | 270018892 | 1.73 | 82.6 | Curative (C) | 2016-04-03 | 2016-04-07 | DHAP | 02 | N | 270020574 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270009754 | 270018892 | 1.58 | 55.4 | Palliative (P) | 2016-11-24 | 2016-12-02 | Enzalutamide | N | N | 270020574 | CVP |
| 270009755 | 270020010 | null | null | Curative (C) | null | 2015-12-13 | null | null | null | 270020593 | CETUXIMAB + RT |
| 270009756 | 270020010 | 1.5 | 83.5 | null | 2015-02-22 | 2015-02-22 | Vinblastine | 02 | N | 270020593 | VINBLASTINE |
| 270009757 | 270005762 | 1.73 | 54.9 | Curative (C) | 2015-11-26 | 2015-12-10 | IVE | N | N | 270020606 | ABVD R |
| 270009758 | 270005763 | 1.73 | 57.8 | Curative (C) | 2015-07-06 | 2015-07-14 | R ABVD | N | N | 270020608 | NOT MATCHED |
| 270009760 | 270012838 | null | 73.3 | Curative (C) | 2013-04-03 | 2013-05-08 | ECHELON 1 TRIAL | N | N | 270020621 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270009761 | 270005765 | null | 72.6 | Curative (C) | 2015-07-19 | 2015-07-19 | CVP | 02 | Y | 270020626 | BENDAMUSTINE + RITUXIMAB |
| 270009762 | 270005765 | null | 60 | Curative (C) | 2013-06-05 | 2013-06-05 | ECHELON 1 TRIAL | null | null | 270020626 | NOT MATCHED |
| 270009763 | 270016037 | 1.63 | null | Palliative (P) | 2015-10-20 | 2015-10-27 | null | null | null | 270020638 | RITUXIMAB |
| 270009764 | 270005766 | 1.65 | 69.4 | Curative (C) | 2015-10-19 | 2015-10-19 | R ABVD | N | N | 270020640 | BREVITY TRIAL |
| 270009765 | 270005766 | 1.69 | 119 | Not known (9) | 2013-10-11 | 2013-10-11 | Chlorambucil | 02 | null | 270020640 | GEMCITABINE + PACLITAXEL |
| 270009766 | 270005767 | 1.6 | 106.7 | Curative (C) | 2013-05-06 | 2013-05-06 | CVP R | 2 | null | 270020647 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270009767 | 270005768 | 1.6 | -1 | Disease modification (D) | 2015-10-29 | 2015-10-30 | Rituximab | 02 | N | 270020661 | CVP R |
| 270009768 | 270005769 | null | null | Curative (C) | 2013-02-03 | 2013-02-03 | IBRUTINIB | N | N | 270020662 | BRENTUXIMAB |
| 270009769 | 270012841 | 1.6 | 53.9 | Disease modification (D) | 2015-09-19 | 2016-02-05 | BREVITY TRIAL | 02 | N | 270020669 | ECHELON 1 TRIAL |
| 270009770 | 270016038 | 1.88 | 54.5 | Curative (C) | 2015-06-29 | 2015-06-29 | BEAM + FLUDARABINE | N | N | 270020672 | GDP |
| 270009771 | 270005770 | 1.81 | 128 | Curative (C) | 2016-06-23 | 2016-07-04 | COPP + Dacarbazine | 02 | N | 270020677 | ABVD R |
| 270009772 | 270005770 | 1.68 | 77.8 | null | 2016-04-24 | 2016-05-01 | ESHAP | 2 | N | 270020677 | NOT MATCHED |
| 270009773 | 270005771 | 1.73 | 60.6 | Palliative (P) | 2014-06-19 | 2014-06-20 | CVP R | N | N | 270020683 | CHOP |
| 270009774 | 270005772 | null | 111.75 | Curative (C) | 2016-08-23 | 2016-08-31 | CVP R | N | N | 270020693 | RITUXIMAB |
| 270009775 | 270005773 | null | 63.25 | Curative (C) | 2014-12-13 | 2015-01-05 | GDCVP | N | Y | 270020697 | CYCLOPHOSPHAMIDE |
| 270009776 | 270005773 | 1.79 | 97.4 | Curative (C) | 2014-08-15 | 2014-08-30 | null | N | Y | 270020697 | NOT MATCHED |
| 270009777 | 270005774 | 1.66 | 53.3 | Curative (C) | 2017-09-12 | 2017-09-21 | CETUXIMAB + RT | N | N | 270020702 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270009778 | 270012844 | 1.93 | 67 | Curative (C) | 2015-02-26 | 2015-03-03 | CVP R | N | N | 270020706 | RITUXIMAB |
| 270009779 | 270005775 | 1.7 | 85.7 | null | 2017-11-25 | 2017-12-08 | null | 02 | null | 270020719 | CVP R |
| 270009780 | 270012845 | null | 68.8 | Curative (C) | null | 2016-11-13 | VEDex | N | N | 270020736 | BREVITY TRIAL |
| 270009781 | 270012845 | 1.65 | 97.8 | Curative (C) | null | 2017-11-10 | Vinblastine | null | null | 270020736 | ABVD R |
| 270009782 | 270012845 | 1.81 | 90.1 | Curative (C) | 2017-01-03 | 2017-02-03 | IVE | N | Y | 270020736 | ESHAP |
| 270009783 | 270005776 | 1.78 | 50 | Curative (C) | 2013-06-14 | 2013-06-20 | Vinblastine | Y | null | 270020762 | NOT MATCHED |
| 270009784 | 270005777 | 1.68 | 78.4 | Curative (C) | 2014-02-04 | 2014-02-10 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270020772 | TRIFLURIDINE + TIPIRACIL |
| 270009785 | 270012846 | null | 85.6 | Palliative (P) | null | 2015-10-07 | Vinblastine | null | null | 270020775 | METHOTREXATE |
| 270009786 | 270005778 | 1.85 | null | Curative (C) | 2015-05-01 | 2015-05-24 | NHL 2003 Gp C COPADM 1 | N | N | 270020778 | CVP R |
| 270009787 | 270005778 | 0 | 89.35 | Curative (C) | 2013-11-06 | 2013-11-12 | Methotrexate intrathecal | N | N | 270020778 | BENDAMUSTINE + RITUXIMAB |
| 270009788 | 270016040 | null | null | null | null | 2013-07-18 | GEMCITABINE + NAB PACLITAXEL | null | null | 270020793 | IPILIMUMAB |
| 270009789 | 270005779 | null | 45 | Disease modification (D) | 2016-01-12 | 2016-01-26 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270020795 | DHAP |
| 270009790 | 270012848 | null | 78 | Palliative (P) | null | 2018-01-13 | Rituximab | Y | null | 270020796 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 270009791 | 270016041 | null | 119.4 | Curative (C) | null | 2016-04-23 | CAPECITABINE + MITOMYCIN + RT | null | null | 270020802 | FLUOROURACIL + MITOMYCIN |
| 270009792 | 270016041 | 1.63 | 87.8 | Neo-adjuvant (N) | 2015-11-11 | 2015-11-14 | CVP R | N | N | 270020802 | ECHELON-1 TRIAL |
| 270009793 | 270005780 | 1.84 | 98.65 | Palliative (P) | 2014-08-23 | 2014-08-30 | IVE | Y | N | 270020822 | CHOP |
| 270009794 | 270005781 | 1.56 | null | Curative (C) | 2014-05-27 | 2014-05-27 | BENDAMUSTINE + RITUXIMAB | N | N | 270020834 | CVP R |
| 270009795 | 270012849 | 1.57 | 72 | Curative (C) | 2014-04-04 | 2014-04-21 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 2 | N | 270020841 | NOT MATCHED |
| 270009796 | 270012849 | 1.76 | null | Palliative (P) | 2016-03-08 | 2016-03-15 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270020841 | CYTARABINE HIGH DOSE |
| 270009797 | 270005782 | 1.84 | 58.5 | Curative (C) | 2015-04-16 | 2015-05-07 | Brentuximab Vedotin | N | N | 270020860 | DACARBAZINE |
| 270009798 | 270005783 | 1.81 | 80.4 | Curative (C) | 2015-08-26 | 2015-08-29 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270020870 | CVP R |
| 270009799 | 270005784 | 1.6 | 51 | Curative (C) | 2016-02-26 | 2016-03-10 | Brentuximab | N | N | 270020891 | ABVD R |
| 270009800 | 270005784 | 1.77 | null | null | 2014-03-23 | 2014-03-28 | Vinblastine | 99 | null | 270020891 | NOT MATCHED |